The numbers of memory Tfh cells and ICOS+ memory Tfh cells in MS patients before and after treatment were significantly greater than that in the HC although the numbers of these cells in MS patients after treatment were significantly reduced (Fig 1A, 1B and 1E). The gene discussed is ICOS; the disease is myeloid sarcoma.